![](/img/cover-not-exists.png)
449 Treatment of pancreatic cancer by TGF-beta2 suppression mediated by the antisense oligonucleotide AP 12009: preclinical efficacy data
G. Stauder, A. Bischof, T. Egger, M. Hafner, H. Herrmuth, M. Kielmanocwicz, P. Jachimczak, R. Schlingensiepen, K. SchlingensiepenVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80457-9
File:
PDF, 135 KB
english, 2004